Viemed Healthcare, Inc.
VMDNASDAQHealthcare● Active
$9.92
$-0.05(-0.50%)
Market Cap$380301086
P/E Ratio—
52W High$10.19
52W Low$5.93
Viemed Healthcare, Inc. (VMD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
VMD · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.06
Est. $0.09 · -33.3%
Revenue
$0.08B
Est. $0.07B · +1.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
VMD reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $0.10 | — | — | — | $0.08B | — |
| ▼ Q2 FY2026 | May 5, 2026 | $0.09 | $0.06 | -33.3% | $0.08B | $0.07B | +1.4% |
| ▲ Q1 FY2026 | Mar 4, 2026 | $0.12 | $0.14 | +16.7% | $0.08B | $0.08B | -1.9% |
| — Q4 FY2025 | Nov 5, 2025 | $0.09 | $0.09 | +0.0% | $0.07B | $0.08B | -7.5% |
| ▼ Q3 FY2025 | Aug 6, 2025 | $0.09 | $0.08 | -5.9% | $0.06B | $0.06B | -0.7% |
| — Q2 FY2025 | May 7, 2025 | $0.06 | $0.06 | +0.0% | $0.06B | $0.06B | -2.4% |
| ▼ Q1 FY2025 | Mar 10, 2025 | $0.11 | $0.10 | -9.1% | $0.06B | $0.06B | +2.2% |
| ▲ Q4 FY2024 | Nov 6, 2024 | $0.08 | $0.10 | +25.0% | $0.06B | $0.06B | -2.4% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$0.10
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Miss
EPS Actual
$0.06
EPS Est.
$0.09
EPS Surpr.
-33.3%
Revenue
$0.08B
Q1 FY2026
Mar 4, 2026Beat
EPS Actual
$0.14
EPS Est.
$0.12
EPS Surpr.
+16.7%
Revenue
$0.08B
Q4 FY2025
Nov 5, 2025
EPS Actual
$0.09
EPS Est.
$0.09
EPS Surpr.
+0.0%
Revenue
$0.07B
Q3 FY2025
Aug 6, 2025Miss
EPS Actual
$0.08
EPS Est.
$0.09
EPS Surpr.
-5.9%
Revenue
$0.06B
Q2 FY2025
May 7, 2025
EPS Actual
$0.06
EPS Est.
$0.06
EPS Surpr.
+0.0%
Revenue
$0.06B
Q1 FY2025
Mar 10, 2025Miss
EPS Actual
$0.10
EPS Est.
$0.11
EPS Surpr.
-9.1%
Revenue
$0.06B
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
$0.10
EPS Est.
$0.08
EPS Surpr.
+25.0%
Revenue
$0.06B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.20 | $0.20 | $0.20 | 1 |
| Q3 FY2027 | $0.15 | $0.15 | $0.15 | 1 |
| Q2 FY2027 | $0.13 | $0.13 | $0.13 | 1 |
| Q1 FY2027 | $0.11 | $0.12 | $0.12 | 1 |
| Q4 FY2026 | $0.15 | $0.15 | $0.15 | 1 |
| Q3 FY2026 | $0.13 | $0.13 | $0.13 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 5, 2026 | -33.3% | $9.48 | $9.70 | +2.32% |
| ▲ Q1 FY2026 | Mar 4, 2026 | +16.7% | $8.95 | $9.08 | +1.45% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +0.0% | $6.54 | $6.43 | -1.68% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -5.9% | $6.32 | $6.45 | +2.06% |
| ▲ Q2 FY2025 | May 7, 2025 | +0.0% | $7.40 | $7.27 | -1.76% |
| ▼ Q1 FY2025 | Mar 10, 2025 | -9.1% | $7.50 | $7.40 | -1.33% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +25.0% | $8.80 | $9.14 | +3.86% |
| ▼ Q3 FY2024 | Aug 7, 2024 | -42.9% | $6.76 | $6.53 | -3.40% |
Q2 FY2026+2.32%
Report Date
May 5, 2026
EPS Beat/Miss
-33.3%
Price Before
$9.48
Price After
$9.70
Q1 FY2026+1.45%
Report Date
Mar 4, 2026
EPS Beat/Miss
+16.7%
Price Before
$8.95
Price After
$9.08
Q4 FY2025-1.68%
Report Date
Nov 5, 2025
EPS Beat/Miss
+0.0%
Price Before
$6.54
Price After
$6.43
Q3 FY2025+2.06%
Report Date
Aug 6, 2025
EPS Beat/Miss
-5.9%
Price Before
$6.32
Price After
$6.45
Q2 FY2025-1.76%
Report Date
May 7, 2025
EPS Beat/Miss
+0.0%
Price Before
$7.40
Price After
$7.27
Q1 FY2025-1.33%
Report Date
Mar 10, 2025
EPS Beat/Miss
-9.1%
Price Before
$7.50
Price After
$7.40
Q4 FY2024+3.86%
Report Date
Nov 6, 2024
EPS Beat/Miss
+25.0%
Price Before
$8.80
Price After
$9.14
Q3 FY2024-3.40%
Report Date
Aug 7, 2024
EPS Beat/Miss
-42.9%
Price Before
$6.76
Price After
$6.53
Avg Beat Reaction+0.47%
Avg Miss Reaction-0.09%
Beat Rate4 / 8 quarters
Largest Move+3.86% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: VMD ends December
Viemed Healthcare, Inc. (VMD) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.06 — missing the analyst consensus of $0.09 by -33.3%. The next VMD earnings date is expected around September 1, 2026.
Each quarter, investors track VMD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. VMD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
VMD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
VMD earnings · 5 questionsViemed Healthcare, Inc.'s next earnings report is expected around September 1, 2026. VMD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; VMD historically reports after market close (AMC).
VMD earnings datewhen is VMD earningsVMD next earnings datewhen does VMD report earningsVMD earnings calendar
▸ Source: FMP · Viemed Healthcare, Inc. SEC filings · US GAAP · Viemed Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026